291 related articles for article (PubMed ID: 19491132)
1. New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?
Van de Werf F
Eur Heart J; 2009 Jul; 30(14):1695-702. PubMed ID: 19491132
[TBL] [Abstract][Full Text] [Related]
2. The medical management of acute coronary syndromes and potential roles for new antithrombotic agents.
Pollack CV; Goldberg AD
J Emerg Med; 2008 May; 34(4):417-28. PubMed ID: 18226874
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet agents in acute coronary syndromes.
Eikelboom JW; Anand S
Semin Vasc Med; 2003 Nov; 3(4):403-14. PubMed ID: 15199447
[TBL] [Abstract][Full Text] [Related]
4. [Antithrombotic therapy of acute coronary syndromes].
Hölschermann H
Hamostaseologie; 2007 Dec; 27(5):319-25; quiz 326-7. PubMed ID: 18060240
[TBL] [Abstract][Full Text] [Related]
5. Tailored antithrombotic therapy for acute coronary syndromes.
Fitchett D
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
[TBL] [Abstract][Full Text] [Related]
6. [Platelet activation in acute coronary syndrome and interventional therapy].
Bigalke B; Lindemann S; Gawaz M
Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
[TBL] [Abstract][Full Text] [Related]
7. Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies.
Goldstein P; Lapostolle F; Steg G; Danchin N; Assez N; Montalescot G; Charpentier S; Wiel E; Juliard JM
Eur J Emerg Med; 2009 Oct; 16(5):244-55. PubMed ID: 19318957
[TBL] [Abstract][Full Text] [Related]
8. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit?
Collet JP; Montalescot G
Int J Cardiol; 2009 Mar; 133(1):8-17. PubMed ID: 19187982
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
Cross J
Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic treatment in acute coronary syndromes.
Hoole SP; Saw J
Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events.
Zhang LJ; Chen YD; Song XT; Zhao FH; Lü SZ
Chin Med J (Engl); 2009 Mar; 122(5):502-8. PubMed ID: 19323898
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agents.
Angiolillo DJ; Ferreiro JL
Am J Cardiovasc Drugs; 2013 Aug; 13(4):233-50. PubMed ID: 23613159
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant agents in acute coronary syndromes.
Sakhuja R; Yeh RW; Bhatt DL
Curr Probl Cardiol; 2011 Apr; 36(4):127-68. PubMed ID: 21586352
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic strategies to reduce adverse clinical outcomes in patients with acute coronary syndrome.
Brieger D
Am J Cardiol; 2012 Oct; 110(8):1200-6. PubMed ID: 22840845
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
Gibson CM
J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
[TBL] [Abstract][Full Text] [Related]
16. Current antithrombotic agents for acute coronary syndromes: focus on bleeding risk.
Bassand JP
Int J Cardiol; 2013 Feb; 163(1):5-18. PubMed ID: 22100180
[TBL] [Abstract][Full Text] [Related]
17. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
[TBL] [Abstract][Full Text] [Related]
18. [Factor Xa-inhibition in interventional cardiology].
Ahrens I; Peter K; Bode C
Hamostaseologie; 2007 Dec; 27(5):328-32. PubMed ID: 18060241
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.
Sculpher MJ; Lozano-Ortega G; Sambrook J; Palmer S; Ormanidhi O; Bakhai A; Flather M; Steg PG; Mehta SR; Weintraub W
Am Heart J; 2009 May; 157(5):845-52. PubMed ID: 19376310
[TBL] [Abstract][Full Text] [Related]
20. [Antithrombotic treatments in acute coronary syndromes with persistent ST-segment elevation].
Aubry P; Halna du Fretay X
Ann Cardiol Angeiol (Paris); 2010 Dec; 59(6):335-43. PubMed ID: 21056405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
